Evaluating the Safety and Immunogenicity of MTBVAC

Clinical trial NCT05947890 · RECRUITING

Trial details

NCT number: NCT05947890
Sponsor: HIV Vaccine Trials Network
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HIV I Infection Tuberculosis

Start date: 2024-01-30
Primary completion: 2027-04-05
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.